Skip to main content

Table 3 Comparison between post-Kasai patients and other cholestatic patients before intervention

From: Zinc status in infants and children with cholestatic liver diseases and its effect on growth

VariablesCholestasis (n = 28)Post-Kasai (n = 27)P value
MUAC Z-score (median (IQR), [range])− 1.5 (2.2), [− 5.8:0.83]− 1.2 (1.7), [− 5.9:0.92]> 0.05
MUAC percentile (median (IQR), [range])6.5 (44), [0.00:80]12 (38), [0.00:82]> 0.05
TSF Z-score (median (IQR), [range])− 2.8 (1.2), [− 7.73:− 0.07]− 2.2 (2.2), [− 7.6:0.2]> 0.05
TSF percentile (median (IQR), [range])0.00 (1), [0.00:47]1 (10), [0.00:58]> 0.05
Weight Z-score (median (IQR), [range])− 1.5 (1.8), [− 3.9:6.3]− 0.6 (1.8), [− 5.5:0.9]> 0.05
Weight percentile (median (IQR), [range])4 (21), [0.00:97]22.5 (41.7), [− 2.7:81]> 0.05
Height (length) Z-score (median (IQR), [range])− 1.8 (1.7), [− 4.8:2.4]− 0.9 (2.8), [− 3.6:41]> 0.05
Height (length) percentile (median (IQR), [range])3 (11), [0.00:99]14.5 (44.5), [− 0.2:92]> 0.05
Serum Zn (mean ± SD) μg/l1222 ± 5121282 ± 610> 0.05
IGF-1 (median (IQR), [range]) ng/ml46 (81), [10:550]57 (369), [18:780]> 0.05
  1. *P < 0.05 is significant